Emerald Acquisition’s Halozyme HALO Stock Holding History

Emerald Acquisition’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$85K	Buy	+7,037	New	+$71.9K	﹤0.01%	2833

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition's HALO Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Halozyme (HALO) in Q3 2016: 7,037 shares worth $85K. The stake represents ﹤0.01% of the portfolio and ranks #2833 among its holdings.

162 funds tracked by Wall St. Rank hold HALO as of Q3 2016.

Emerald Acquisition held 7,037 shares of Halozyme worth $85K as of Q3 2016.
Halozyme was a new Emerald Acquisition position in Q3 2016.
Halozyme made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2833 holding.
162 funds tracked by Wall St. Rank held Halozyme as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.